# IlluminOss Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/illuminoss-medical

- Industry: Medical Devices & Equipment
- Headquarters: East Providence, US
- Website: www.illuminoss.com
- Total disclosed funding: $39M
- Latest round: Series C (Jun 13, 2014)
- Investors on record: 9

## About

IlluminOss Medical, Inc., based in the US, specializes in innovative orthopedic solutions focused on bone stabilization and fracture repair through minimally invasive technologies.Founded in 2007 in East Providence, US, IlluminOss Medical, Inc. develops orthopedic solutions that utilize unique light-curable polymer technology. The company has engaged in 10 investment deals, with the most recent deal occurring on May 1, 2020. IlluminOss raised a total of USD 5.00 mn, attracting investment from Pappas Capital. Robert Rabiner is the founder of the company.IlluminOss specializes in innovative orthopedic solutions that primarily focus on bone stabilization and fracture repair. Their core product, the IlluminOss System, utilizes a unique light-curable polymer technology that allows for minimally invasive procedures in orthopedic surgery. This system is designed to strengthen and stabilize bones internally, addressing complex issues such as fractures and deformities in patients. The product is particularly beneficial for hospitals and orthopedic surgeons, who require effective solutions for treating patients with challenging bone conditions. IlluminOss’s products are distributed across various international markets, including North America, Europe, and parts of Asia, catering to a diverse clientele that includes healthcare professionals and patients requiring surgical intervention.IlluminOss generates revenue primarily through direct sales of its flagship product, the IlluminOss System, to healthcare institutions and surgical centers. The structure of transactions typically involves B2B sales where hospitals and clinics purchase the system alongside necessary consumables for procedures. These healthcare providers may enter into contractual agreements that ensure a consistent supply of the technology needed for orthopedic surgeries. Pricing plans for the IlluminOss System are structured to reflect the specialized nature of the technology and its application in complex surgical procedures, allowing healthcare providers to budget for both initial procurement and ongoing usage. The company’s revenue model is supported by establishing partnerships with healthcare organizations and distributors, further enhancing their market reach and client engagement.IlluminOss plans to leverage its recent funding of USD 5.00 mn from May 2020 to further its development of the IlluminOss System and explore new market opportunities. The company is focused on launching additional products designed for advanced orthopedic solutions while expanding its presence in regions such as Europe and Asia by 2023. The recent acquisition by HealthPointCapital has also positioned the company to enhance its operational capabilities and broaden its market reach.

## Funding rounds

- Series C, Jun 13, 2014, $6.5M — Foundation Medical Partners, EQT Life Sciences, Pappas Capital, Excel Venture Management, Slater Technology Fund
- Series C, Sep 26, 2012, $19M — Foundation Medical Partners, EQT Life Sciences, Pappas Capital, SR One, New Leaf Venture Partners, Tekla Capital Management, Excel Venture Management, Slater Technology Fund, Mieza Capital
- Series B, Apr 18, 2008, $11M — Foundation Medical Partners, New Leaf Venture Partners, Mieza Capital
- Series A, Mar 30, 2007, $2.7M — Foundation Medical Partners

## Investors

- Foundation Medical Partners (https://capitalatlas.ai/funds/foundation-medical-partners) — Series A, Series B, Series C
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series B, Series C
- Mieza Capital — Series B, Series C
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series C
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series C
- SR One (https://capitalatlas.ai/funds/sr-one) — Series C
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series C
- Excel Venture Management (https://capitalatlas.ai/funds/excel-venture-management) — Series C
- Slater Technology Fund (https://capitalatlas.ai/funds/slater-technology-fund) — Series C